USPTO serial 79219910
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Adam D. Mandell
Adam D. Mandell Millen, White, Zelano & Branigan, P.C.2200 Clarendon Blvd., Ste 1400Arlington, VA 22201United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compositions, namely, polypeptides, proteins or peptides in raw form for scientific research, namely, for analysis of polypeptide, protein and peptide interaction, all of the foregoing not for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents, and/or compositions, namely, diagnostic preparations for medical [ and veterinary ] use, therapeutic preparations for medical [ and veterinary use, namely, medicated bath preparations, ] pharmaceutical preparations for the medical treatment of cancer, metabolic, inflammatory, skin, eye and cardiovascular diseases, and chemical reagents for medical or veterinary purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and analysis in the fields of pharmaceutical, diagnostic, analytical or biochemical substances; scientific and technological services, namely, scientific research in the fields of the identification, further development, and use of biochemical, pharmaceutical, analytical and diagnostic products; scientific laboratory services in the fields of molecular biological, biotechnological, biochemical or pharmaceutical products; research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kits | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 22, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 21, 2026 | INPC | INVALIDATION PROCESSED | — |
| Dec 28, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 28, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 28, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 28, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 18, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 8, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 3, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 11, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 11, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 8, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 8, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 23, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 23, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 3, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 3, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 3, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2018 | PBER | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST | — |
| Aug 31, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 31, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 12, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 12, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 12, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 24, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 30, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 30, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 17, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 16, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 2, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |